IOSP logo

Innospec (IOSP) Cash From Financing

Annual CFF

-$39.00 M
-$5.30 M-15.73%

December 31, 2023


Summary


Performance

IOSP Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIOSPcash flowmetrics:

Quarterly CFF

$900.00 K
+$19.80 M+104.76%

September 30, 2024


Summary


Performance

IOSP Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIOSPcash flowmetrics:

TTM CFF

-$37.90 M
+$700.00 K+1.81%

September 30, 2024


Summary


Performance

IOSP TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIOSPcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IOSP Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.7%+104.8%+1.8%
3 y3 years+55.1%0.0%-101.6%
5 y5 years-7.7%+107.5%+56.3%

IOSP Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.0%at lowat high+104.4%-101.6%+2.8%
5 y5-year-95.0%+78.1%at high+101.0%-101.6%+78.7%
alltimeall time-134.6%+80.1%-99.3%+101.0%-133.6%+80.7%

Innospec Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$900.00 K(-104.8%)
-$37.90 M(-1.8%)
Jun 2024
-
-$18.90 M(-3880.0%)
-$38.60 M(-0.8%)
Mar 2024
-
$500.00 K(-102.5%)
-$38.90 M(-0.3%)
Dec 2023
-$39.00 M(+15.7%)
-$20.40 M(<-9900.0%)
-$39.00 M(+9.6%)
Sep 2023
-
$200.00 K(-101.0%)
-$35.60 M(-1.7%)
Jun 2023
-
-$19.20 M(-4900.0%)
-$36.20 M(+5.8%)
Mar 2023
-
$400.00 K(-102.4%)
-$34.20 M(+1.5%)
Dec 2022
-$33.70 M(+68.5%)
-$17.00 M(+4150.0%)
-$33.70 M(+43.4%)
Sep 2022
-
-$400.00 K(-97.7%)
-$23.50 M(+2.2%)
Jun 2022
-
-$17.20 M(-2011.1%)
-$23.00 M(+22.3%)
Mar 2022
-
$900.00 K(-113.2%)
-$18.80 M(-6.0%)
Dec 2021
-$20.00 M(-77.0%)
-$6.80 M(-6900.0%)
-$20.00 M(-20.6%)
Sep 2021
-
$100.00 K(-100.8%)
-$25.20 M(-61.5%)
Jun 2021
-
-$13.00 M(+4233.3%)
-$65.50 M(-23.4%)
Mar 2021
-
-$300.00 K(-97.5%)
-$85.50 M(-1.5%)
Dec 2020
-$86.80 M(-51.2%)
-$12.00 M(-70.1%)
-$86.80 M(-46.1%)
Sep 2020
-
-$40.20 M(+21.8%)
-$160.90 M(+7.8%)
Jun 2020
-
-$33.00 M(+1962.5%)
-$149.30 M(-16.1%)
Mar 2020
-
-$1.60 M(-98.1%)
-$178.00 M(+0.1%)
Dec 2019
-$177.90 M(+391.4%)
-$86.10 M(+201.0%)
-$177.90 M(+47.5%)
Sep 2019
-
-$28.60 M(-53.6%)
-$120.60 M(+30.8%)
Jun 2019
-
-$61.70 M(+4013.3%)
-$92.20 M(+189.0%)
Mar 2019
-
-$1.50 M(-94.8%)
-$31.90 M(-11.9%)
Dec 2018
-$36.20 M(-45.5%)
-$28.80 M(>+9900.0%)
-$36.20 M(+58.1%)
Sep 2018
-
-$200.00 K(-85.7%)
-$22.90 M(-47.1%)
Jun 2018
-
-$1.40 M(-75.9%)
-$43.30 M(+3.8%)
Mar 2018
-
-$5.80 M(-62.6%)
-$41.70 M(-37.2%)
Dec 2017
-$66.40 M(-195.5%)
-$15.50 M(-24.8%)
-$66.40 M(-195.7%)
Sep 2017
-
-$20.60 M(<-9900.0%)
$69.40 M(-11.7%)
Jun 2017
-
$200.00 K(-100.7%)
$78.60 M(+10.1%)
Mar 2017
-
-$30.50 M(-125.4%)
$71.40 M(+2.7%)
Dec 2016
$69.50 M(-288.9%)
$120.30 M(-1155.3%)
$69.50 M(-211.7%)
Sep 2016
-
-$11.40 M(+62.9%)
-$62.20 M(+5.6%)
Jun 2016
-
-$7.00 M(-78.4%)
-$58.90 M(-8.1%)
Mar 2016
-
-$32.40 M(+184.2%)
-$64.10 M(+74.2%)
Dec 2015
-$36.80 M(+51.4%)
-$11.40 M(+40.7%)
-$36.80 M(+140.5%)
Sep 2015
-
-$8.10 M(-33.6%)
-$15.30 M(-42.7%)
Jun 2015
-
-$12.20 M(+139.2%)
-$26.70 M(+24.8%)
Mar 2015
-
-$5.10 M(-150.5%)
-$21.40 M(-11.9%)
Dec 2014
-$24.30 M(-121.5%)
$10.10 M(-151.8%)
-$24.30 M(-317.0%)
Sep 2014
-
-$19.50 M(+182.6%)
$11.20 M(-88.2%)
Jun 2014
-
-$6.90 M(-13.8%)
$95.30 M(-2.0%)
Mar 2014
-
-$8.00 M(-117.5%)
$97.20 M(-13.8%)
Dec 2013
$112.80 M(-352.3%)
$45.60 M(-29.4%)
$112.80 M(+563.5%)
Sep 2013
-
$64.60 M(-1392.0%)
$17.00 M(-135.3%)
Jun 2013
-
-$5.00 M(-165.8%)
-$48.20 M(+26.5%)
Mar 2013
-
$7.60 M(-115.1%)
-$38.10 M(-14.8%)
Dec 2012
-$44.70 M(-18.7%)
-$50.20 M(+8266.7%)
-$44.70 M(-25.4%)
Sep 2012
-
-$600.00 K(-111.8%)
-$59.90 M(+83.2%)
Jun 2012
-
$5.10 M(+410.0%)
-$32.70 M(+3.2%)
Mar 2012
-
$1.00 M(-101.5%)
-$31.70 M(-42.4%)
Dec 2011
-$55.00 M
-$65.40 M(-345.9%)
-$55.00 M(-885.7%)
Sep 2011
-
$26.60 M(+336.1%)
$7.00 M(-137.6%)
DateAnnualQuarterlyTTM
Jun 2011
-
$6.10 M(-127.4%)
-$18.60 M(-18.1%)
Mar 2011
-
-$22.30 M(+555.9%)
-$22.70 M(+249.2%)
Dec 2010
-$6.50 M(-75.6%)
-$3.40 M(-440.0%)
-$6.50 M(-50.8%)
Sep 2010
-
$1.00 M(-50.0%)
-$13.20 M(-30.5%)
Jun 2010
-
$2.00 M(-132.8%)
-$19.00 M(-34.7%)
Mar 2010
-
-$6.10 M(-39.6%)
-$29.10 M(+9.4%)
Dec 2009
-$26.60 M(+56.5%)
-$10.10 M(+110.4%)
-$26.60 M(-29.3%)
Sep 2009
-
-$4.80 M(-40.7%)
-$37.60 M(+79.9%)
Jun 2009
-
-$8.10 M(+125.0%)
-$20.90 M(-367.9%)
Mar 2009
-
-$3.60 M(-82.9%)
$7.80 M(-145.9%)
Dec 2008
-$17.00 M(-80.0%)
-$21.10 M(-277.3%)
-$17.00 M(-20.2%)
Sep 2008
-
$11.90 M(-42.2%)
-$21.30 M(-62.5%)
Jun 2008
-
$20.60 M(-172.5%)
-$56.80 M(+49.1%)
Mar 2008
-
-$28.40 M(+11.8%)
-$38.10 M(-55.2%)
Dec 2007
-$85.10 M(+1050.0%)
-$25.40 M(+7.6%)
-$85.10 M(+40.9%)
Sep 2007
-
-$23.60 M(-160.1%)
-$60.40 M(+54.9%)
Jun 2007
-
$39.30 M(-152.1%)
-$39.00 M(-53.0%)
Mar 2007
-
-$75.40 M(>+9900.0%)
-$83.00 M(+1021.6%)
Dec 2006
-$7.40 M(-147.7%)
-$700.00 K(-68.2%)
-$7.40 M(-75.4%)
Sep 2006
-
-$2.20 M(-53.2%)
-$30.10 M(+246.0%)
Jun 2006
-
-$4.70 M(-2450.0%)
-$8.70 M(+38.1%)
Mar 2006
-
$200.00 K(-100.9%)
-$6.30 M(-140.6%)
Dec 2005
$15.50 M(+86.7%)
-$23.40 M(-221.9%)
$15.50 M(+56.6%)
Sep 2005
-
$19.20 M(-934.8%)
$9.90 M(-61.5%)
Jun 2005
-
-$2.30 M(-110.5%)
$25.70 M(-4.1%)
Mar 2005
-
$22.00 M(-175.9%)
$26.80 M(+222.9%)
Dec 2004
$8.30 M(-115.6%)
-$29.00 M(-182.9%)
$8.30 M(-27.2%)
Sep 2004
-
$35.00 M(-3016.7%)
$11.40 M(-125.1%)
Jun 2004
-
-$1.20 M(-134.3%)
-$45.40 M(-4.8%)
Mar 2004
-
$3.50 M(-113.5%)
-$47.70 M(-10.3%)
Dec 2003
-$53.20 M(-28.1%)
-$25.90 M(+18.8%)
-$53.20 M(+38.5%)
Sep 2003
-
-$21.80 M(+522.9%)
-$38.40 M(+42.2%)
Jun 2003
-
-$3.50 M(+75.0%)
-$27.00 M(-20.1%)
Mar 2003
-
-$2.00 M(-82.0%)
-$33.80 M(-54.3%)
Dec 2002
-$74.00 M(>+9900.0%)
-$11.10 M(+6.7%)
-$74.00 M(+25.0%)
Sep 2002
-
-$10.40 M(+1.0%)
-$59.20 M(+33.0%)
Jun 2002
-
-$10.30 M(-75.6%)
-$44.50 M(+3.5%)
Mar 2002
-
-$42.20 M(-1240.5%)
-$43.00 M(+7066.7%)
Dec 2001
-$600.00 K(-99.5%)
$3.70 M(-14.0%)
-$600.00 K(-97.5%)
Sep 2001
-
$4.30 M(-148.9%)
-$24.20 M(-55.1%)
Jun 2001
-
-$8.80 M(-4500.0%)
-$53.90 M(-39.1%)
Mar 2001
-
$200.00 K(-101.0%)
-$88.50 M(-23.0%)
Dec 2000
-$114.90 M(+42.2%)
-$19.90 M(-21.7%)
-$114.90 M(-11.3%)
Sep 2000
-
-$25.40 M(-41.5%)
-$129.50 M(+9.2%)
Jun 2000
-
-$43.40 M(+65.6%)
-$118.60 M(+20.2%)
Mar 2000
-
-$26.20 M(-24.1%)
-$98.70 M(+22.2%)
Dec 1999
-$80.80 M(-58.8%)
-$34.50 M(+137.9%)
-$80.80 M(-14.9%)
Sep 1999
-
-$14.50 M(-38.3%)
-$95.00 M(-31.4%)
Jun 1999
-
-$23.50 M(+183.1%)
-$138.40 M(-18.7%)
Mar 1999
-
-$8.30 M(-83.0%)
-$170.20 M(-13.2%)
Dec 1998
-$196.10 M
-$48.70 M(-15.9%)
-$196.10 M(+33.0%)
Sep 1998
-
-$57.90 M(+4.7%)
-$147.40 M(+64.7%)
Jun 1998
-
-$55.30 M(+61.7%)
-$89.50 M(+161.7%)
Mar 1998
-
-$34.20 M
-$34.20 M

FAQ

  • What is Innospec annual cash flow from financing activities?
  • What is the all time high annual CFF for Innospec?
  • What is Innospec annual CFF year-on-year change?
  • What is Innospec quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Innospec?
  • What is Innospec quarterly CFF year-on-year change?
  • What is Innospec TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Innospec?
  • What is Innospec TTM CFF year-on-year change?

What is Innospec annual cash flow from financing activities?

The current annual CFF of IOSP is -$39.00 M

What is the all time high annual CFF for Innospec?

Innospec all-time high annual cash flow from financing activities is $112.80 M

What is Innospec annual CFF year-on-year change?

Over the past year, IOSP annual cash flow from financing activities has changed by -$5.30 M (-15.73%)

What is Innospec quarterly cash flow from financing activities?

The current quarterly CFF of IOSP is $900.00 K

What is the all time high quarterly CFF for Innospec?

Innospec all-time high quarterly cash flow from financing activities is $120.30 M

What is Innospec quarterly CFF year-on-year change?

Over the past year, IOSP quarterly cash flow from financing activities has changed by +$19.80 M (+104.76%)

What is Innospec TTM cash flow from financing activities?

The current TTM CFF of IOSP is -$37.90 M

What is the all time high TTM CFF for Innospec?

Innospec all-time high TTM cash flow from financing activities is $112.80 M

What is Innospec TTM CFF year-on-year change?

Over the past year, IOSP TTM cash flow from financing activities has changed by +$700.00 K (+1.81%)